Copyright
©The Author(s) 2022.
World J Gastroenterol. Aug 7, 2022; 28(29): 3971-3980
Published online Aug 7, 2022. doi: 10.3748/wjg.v28.i29.3971
Published online Aug 7, 2022. doi: 10.3748/wjg.v28.i29.3971
Figure 1 Disease-free survival rates of the patients with primary liver cancer after treatment with microwave ablation.
The disease-free survival (DFS) rates were analyzed at 6, 12, 18, 24, 30, and 36 mo after microwave ablation (MWA) for primary liver cancer in the patients. The 1-, 2-, and 3-year DFS rates after MWA were 74.67%, 59.33%, and 54.00%, respectively. DFS: Disease-free survival.
- Citation: Xu ZJ, Wei MJ, Zhang XM, Liu HG, Wu JP, Huang JF, Li YF, Huang ZJ, Yan YY. Effects of microwave ablation on serum Golgi protein 73 in patients with primary liver cancer. World J Gastroenterol 2022; 28(29): 3971-3980
- URL: https://www.wjgnet.com/1007-9327/full/v28/i29/3971.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i29.3971